Selected research
Industry Research
Opioid Pain Patche Industry Research Report 2026
Market perspective
The global Opioid Pain Patche market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Opioid Pain Patche is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Opioid Pain Patche is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Opioid Pain Patche is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Opioid Pain Patche include Teva Pharmaceutical Industries, Sanofi, Novartis, GlaxoSmithKline, Viatris, Teikoku Seiyaku, Nichiban, Mentholatum and Johnson & Johnson Services, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Opioid Pain Patche market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Opioid Pain Patche Market by Company
Teva Pharmaceutical Industries
Sanofi
Novartis
GlaxoSmithKline
Viatris
Teikoku Seiyaku
Nichiban
Mentholatum
Johnson & Johnson Services
Hisamitsu Pharmaceutical
Opioid Pain Patche Segment by Type
Opioid Patches
Non-opioid Patches
Opioid Pain Patche Segment by Application
Retail Pharmacies
Online pharmacies
Hospital Pharmacies
Opioid Pain Patche Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Opioid Pain Patche market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Opioid Pain Patche and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Opioid Pain Patche.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Opioid Pain Patche manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Opioid Pain Patche by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Opioid Pain Patche in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Opioid Patches
- Non-opioid Patches
Applications
- Retail Pharmacies
- Online pharmacies
- Hospital Pharmacies
Companies covered
- Teva Pharmaceutical Industries
- Sanofi
- Novartis
- GlaxoSmithKline
- Viatris
- Teikoku Seiyaku
- Nichiban
- Mentholatum
- Johnson & Johnson Services
- Hisamitsu Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Opioid Pain Patche Market Size (2021-2032)
- 2.2.2 Global Opioid Pain Patche Sales (2021-2032)
- 2.2.3 Global Opioid Pain Patche Market Average Price (2021-2032)
- 2.3 Opioid Pain Patche by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Opioid Patches
- 2.3.3 Non-opioid Patches
- 2.4 Opioid Pain Patche by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Retail Pharmacies
- 2.4.3 Online pharmacies
- 2.4.4 Hospital Pharmacies
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Opioid Pain Patche Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Opioid Pain Patche Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Opioid Pain Patche Revenue of Manufacturers (2021-2026)
- 3.4 Global Opioid Pain Patche Average Price by Manufacturers (2021-2026)
- 3.5 Global Opioid Pain Patche Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Opioid Pain Patche, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Opioid Pain Patche, Product Type & Application
- 3.8 Global Manufacturers of Opioid Pain Patche, Established Date
- 3.9 Global Opioid Pain Patche Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva Pharmaceutical Industries
- 4.1.1 Teva Pharmaceutical Industries Company Information
- 4.1.2 Teva Pharmaceutical Industries Business Overview
- 4.1.3 Teva Pharmaceutical Industries Opioid Pain Patche Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Pharmaceutical Industries Opioid Pain Patche Product Portfolio
- 4.1.5 Teva Pharmaceutical Industries Recent Developments
- 4.2 Sanofi
- 4.2.1 Sanofi Company Information
- 4.2.2 Sanofi Business Overview
- 4.2.3 Sanofi Opioid Pain Patche Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sanofi Opioid Pain Patche Product Portfolio
- 4.2.5 Sanofi Recent Developments
- 4.3 Novartis
- 4.3.1 Novartis Company Information
- 4.3.2 Novartis Business Overview
- 4.3.3 Novartis Opioid Pain Patche Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Novartis Opioid Pain Patche Product Portfolio
- 4.3.5 Novartis Recent Developments
- 4.4 GlaxoSmithKline
- 4.4.1 GlaxoSmithKline Company Information
- 4.4.2 GlaxoSmithKline Business Overview
- 4.4.3 GlaxoSmithKline Opioid Pain Patche Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 GlaxoSmithKline Opioid Pain Patche Product Portfolio
- 4.4.5 GlaxoSmithKline Recent Developments
- 4.5 Viatris
- 4.5.1 Viatris Company Information
- 4.5.2 Viatris Business Overview
- 4.5.3 Viatris Opioid Pain Patche Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Viatris Opioid Pain Patche Product Portfolio
- 4.5.5 Viatris Recent Developments
- 4.6 Teikoku Seiyaku
- 4.6.1 Teikoku Seiyaku Company Information
- 4.6.2 Teikoku Seiyaku Business Overview
- 4.6.3 Teikoku Seiyaku Opioid Pain Patche Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Teikoku Seiyaku Opioid Pain Patche Product Portfolio
- 4.6.5 Teikoku Seiyaku Recent Developments
- 4.7 Nichiban
- 4.7.1 Nichiban Company Information
- 4.7.2 Nichiban Business Overview
- 4.7.3 Nichiban Opioid Pain Patche Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Nichiban Opioid Pain Patche Product Portfolio
- 4.7.5 Nichiban Recent Developments
- 4.8 Mentholatum
- 4.8.1 Mentholatum Company Information
- 4.8.2 Mentholatum Business Overview
- 4.8.3 Mentholatum Opioid Pain Patche Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Mentholatum Opioid Pain Patche Product Portfolio
- 4.8.5 Mentholatum Recent Developments
- 4.9 Johnson & Johnson Services
- 4.9.1 Johnson & Johnson Services Company Information
- 4.9.2 Johnson & Johnson Services Business Overview
- 4.9.3 Johnson & Johnson Services Opioid Pain Patche Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Johnson & Johnson Services Opioid Pain Patche Product Portfolio
- 4.9.5 Johnson & Johnson Services Recent Developments
- 4.10 Hisamitsu Pharmaceutical
- 4.10.1 Hisamitsu Pharmaceutical Company Information
- 4.10.2 Hisamitsu Pharmaceutical Business Overview
- 4.10.3 Hisamitsu Pharmaceutical Opioid Pain Patche Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Hisamitsu Pharmaceutical Opioid Pain Patche Product Portfolio
- 4.10.5 Hisamitsu Pharmaceutical Recent Developments
5 Global Opioid Pain Patche Market Scenario by Region
- 5.1 Global Opioid Pain Patche Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Opioid Pain Patche Sales by Region: 2021-2032
- 5.2.1 Global Opioid Pain Patche Sales by Region: 2021-2026
- 5.2.2 Global Opioid Pain Patche Sales by Region: 2027-2032
- 5.3 Global Opioid Pain Patche Revenue by Region: 2021-2032
- 5.3.1 Global Opioid Pain Patche Revenue by Region: 2021-2026
- 5.3.2 Global Opioid Pain Patche Revenue by Region: 2027-2032
- 5.4 North America Opioid Pain Patche Market Facts & Figures by Country
- 5.4.1 North America Opioid Pain Patche Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Opioid Pain Patche Sales by Country (2021-2032)
- 5.4.3 North America Opioid Pain Patche Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Opioid Pain Patche Market Facts & Figures by Country
- 5.5.1 Europe Opioid Pain Patche Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Opioid Pain Patche Sales by Country (2021-2032)
- 5.5.3 Europe Opioid Pain Patche Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Opioid Pain Patche Market Facts & Figures by Country
- 5.6.1 Asia Pacific Opioid Pain Patche Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Opioid Pain Patche Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Opioid Pain Patche Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Opioid Pain Patche Market Facts & Figures by Country
- 5.7.1 South America Opioid Pain Patche Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Opioid Pain Patche Sales by Country (2021-2032)
- 5.7.3 South America Opioid Pain Patche Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Opioid Pain Patche Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Opioid Pain Patche Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Opioid Pain Patche Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Opioid Pain Patche Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Opioid Pain Patche Sales by Type (2021-2032)
- 6.1.1 Global Opioid Pain Patche Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Opioid Pain Patche Sales Market Share by Type (2021-2032)
- 6.2 Global Opioid Pain Patche Revenue by Type (2021-2032)
- 6.2.1 Global Opioid Pain Patche Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Opioid Pain Patche Revenue Market Share by Type (2021-2032)
- 6.3 Global Opioid Pain Patche Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Opioid Pain Patche Sales by Application (2021-2032)
- 7.1.1 Global Opioid Pain Patche Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Opioid Pain Patche Sales Market Share by Application (2021-2032)
- 7.2 Global Opioid Pain Patche Revenue by Application (2021-2032)
- 7.2.1 Global Opioid Pain Patche Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Opioid Pain Patche Revenue Market Share by Application (2021-2032)
- 7.3 Global Opioid Pain Patche Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Opioid Pain Patche Value Chain Analysis
- 8.1.1 Opioid Pain Patche Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Opioid Pain Patche Production Mode & Process
- 8.2 Opioid Pain Patche Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Opioid Pain Patche Distributors
- 8.2.3 Opioid Pain Patche Customers
9 Global Opioid Pain Patche Analyzing Market Dynamics
- 9.1 Opioid Pain Patche Industry Trends
- 9.2 Opioid Pain Patche Industry Drivers
- 9.3 Opioid Pain Patche Industry Opportunities and Challenges
- 9.4 Opioid Pain Patche Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst